NENF Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain (aa 32-172) containing 151 amino acids including a 10 a.a N-terminal His tag and having a molecular mass of 16.9kDa.
Recombinant human NENF, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 151 amino acids (aa 32-172). It includes a 10-amino acid N-terminal His tag and has a molecular weight of 16.9 kDa.
To prepare a working stock solution, it is advised to add deionized water to the lyophilized pellet, aiming for a concentration of approximately 0.5 mg/ml. Allow the pellet to dissolve fully. Note that the NENF product is not sterile. Prior to using it in cell culture, it is essential to filter the solution using an appropriate sterile filter.
Human Neudesin is synthesized as a 172 amino acid precursor, which includes a 31 amino acid signal sequence and a 141 amino acid mature region . The mature region contains a cytochrome b5-like heme-binding domain spanning amino acids 44-129 and a lysine acetylation site at amino acid 136 . The attachment of hemin to its heme-binding domain is essential for its neurotrophic activity .
Neudesin exhibits neurotrophic activity, which means it supports the growth, survival, and differentiation of neurons . This activity is mediated through the binding of heme to its heme-binding domain . Neudesin has been shown to activate the MAPK and PI-3K signaling pathways, which are crucial for cell proliferation and survival .
Recombinant human Neudesin is produced using Chinese Hamster Ovary (CHO) cells . The recombinant protein is often tagged with a C-terminal 6-His tag to facilitate purification . The protein is typically lyophilized from a 0.2 μm filtered solution in PBS and can be reconstituted at 500 μg/mL in PBS .
Recombinant Neudesin is used in various research applications, including: